Both in Pharmaceuticals
iBio vs OS Therapies Incorporated
Over the past year IBIO returned +39.9% and OSTX returned −19.9%; their daily moves had a correlation of 0.22.
IBIO +39.9% OSTX −19.9%Growth of $1, one year, split-adjusted
| Metric | IBIO | OSTX |
|---|---|---|
| Price | $1.17 | $1.61 |
| Market cap | $75.2M | $75.4M |
| Today | 0.00% | −2.42% |
| 1 month | −14.0% | −1.8% |
| 6 months | −31.6% | +21.1% |
| Year to date | −39.4% | +15.0% |
| 1 year | +44.3% | −21.5% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 752.4× | — |
| Net cash | $88.0M | $105.0K |
| Dividend yield | — | — |
| Volatility (60d) | 44.1% | 65.6% |
| Short % of float | 8.9% | 5.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).